HCA Healthcare (NYSE:HCA – Get Free Report) had its target price decreased by equities research analysts at Royal Bank of Canada from $405.00 to $384.00 in a report issued on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank of Canada’s target price indicates a potential upside of 16.93% from the company’s previous close.
A number of other research firms have also recently weighed in on HCA. TD Cowen cut their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. Barclays lowered their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday. KeyCorp decreased their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Cantor Fitzgerald restated an “overweight” rating and set a $405.00 price objective on shares of HCA Healthcare in a research report on Monday. Finally, JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a research report on Tuesday, December 17th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $382.19.
HCA Healthcare Stock Down 1.1 %
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 520.98% and a net margin of 8.52%. During the same quarter last year, the business earned $5.90 EPS. As a group, equities research analysts anticipate that HCA Healthcare will post 21.75 EPS for the current year.
Insider Activity
In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.70% of the company’s stock.
Institutional Trading of HCA Healthcare
Several hedge funds have recently made changes to their positions in HCA. Legacy Investment Solutions LLC acquired a new stake in HCA Healthcare during the 3rd quarter worth approximately $39,000. Activest Wealth Management boosted its holdings in HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares during the period. Canoe Financial LP purchased a new stake in HCA Healthcare during the 3rd quarter worth about $41,000. Capital Performance Advisors LLP acquired a new position in shares of HCA Healthcare during the third quarter worth about $41,000. Finally, Northwest Investment Counselors LLC acquired a new stake in HCA Healthcare in the third quarter valued at approximately $44,000. Institutional investors and hedge funds own 62.73% of the company’s stock.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also
- Five stocks we like better than HCA Healthcare
- The Most Important Warren Buffett Stock for Investors: His Own
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- How to Most Effectively Use the MarketBeat Earnings Screener
- What Does the Future Hold for Eli Lilly?
- What is a Low P/E Ratio and What Does it Tell Investors?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.